Get the Stockscreener App
12.85
0.31%
-0.04
Avita Medical Inc stock is traded at $12.85, with a volume of 54,697.
It is down -0.31% in the last 24 hours and up +26.85% over the past month.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$12.89
Open:
$12.94
24h Volume:
54,697
Relative Volume:
0.56
Market Cap:
$340.83M
Revenue:
$50.14M
Net Income/Loss:
$-35.38M
P/E Ratio:
-10.53
EPS:
-1.22
Net Cash Flow:
$-39.46M
1W Performance:
-1.53%
1M Performance:
+26.85%
6M Performance:
+58.64%
1Y Performance:
+18.43%
1-Day Range:
$12.63
$13.04
1-Week Range:
$12.58
$13.70
52-Week Range:
$7.51
$18.93
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
12.85 | 340.83M | 50.14M | -35.38M | -39.46M | -1.22 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
AVITA Medical's SWOT analysis: regenerative medicine firm's stock faces growth hurdles - Investing.com
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference - The Manila Times
AVITA Medical to Present at Piper Sandler Healthcare Conference in December | RCEL Stock News - StockTitan
Trend Tracker for (RCEL) - Stock Traders Daily
AVITA Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
AVHHL (AVITA Medical) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
AVHHL (AVITA Medical) Enterprise Value : $341.00 Mil (As of Nov. 20, 2024) - GuruFocus.com
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand - The Manila Times
AVITA Medical Expands RECELL Platform to Australia, NZ in Strategic Distribution Deal | RCEL Stock News - StockTitan
AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2024 Earnings Call Transcript - Insider Monkey
AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
RCELAvita Medical, Inc. Latest Stock News & Market Updates - StockTitan
AVITA Medical's (RCEL) "Neutral" Rating Reaffirmed at Piper Sandler - MarketBeat
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
AVITA Medical Inc (AVHHL) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Rising Expenses By GuruFocus - Investing.com Canada
AVITA Medical Inc (AVHHL) Q3 2024 Earnings Call Highlights: Reve - GuruFocus.com
RECELL boosts revenue, but AVITA feels the burn - ShareCafe
Avita Medical earnings missed by $0.19, revenue topped estimates - Investing.com UK
AVITA Medical Reports Third Quarter Financial Results - The Manila Times
AVITA Medical Revenue Surges 44% to $19.5M, Despite Widening Losses | Q3 Earnings | RCEL Stock News - StockTitan
AVITA Medical (ASX:AVH) Total Inventories : A$10.10 Mil (As of Jun. 2024) - GuruFocus.com
When (RCEL) Moves Investors should Listen - Stock Traders Daily
AVITA Medical (RCEL) to Release Quarterly Earnings on Thursday - Defense World
AVITA Medical (RCEL) Set to Announce Quarterly Earnings on Thursday - MarketBeat
AVHHL (AVITA Medical) Net Income From Continuing Operations : $-49.83 Mil (TTM As of Jun. 2024) - GuruFocus.com
How the (RCEL) price action is used to our Advantage - Stock Traders Daily
The Manufacturers Life Insurance Company Invests $86,000 in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AQR Capital Management LLC Sells 67,535 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat
Financial Analysis: AVITA Medical (NASDAQ:RCEL) & KORU Medical Systems (NASDAQ:KRMD) - Defense World
Essex Investment Management Co. LLC Invests $2.48 Million in AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat
(RCEL) Long Term Investment Analysis - Stock Traders Daily
AVITA Medical to Announce Third Quarter 2024 Financial Results - The Manila Times
AVITA Medical (NASDAQ:RCEL) shareholders have endured a 74% loss from investing in the stock five years ago - Yahoo Finance
These small cap ASX shares could rise 25% to 100% - The Motley Fool Australia
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - Simply Wall St
AVITA Medical Inc (RCEL) Trading 4.08% Higher on Oct 2 - GuruFocus.com
AVITA Medical Headed For Its Most Important Report, I'm Extremely Bullish - Seeking Alpha
AVITA Medical's SWOT analysis: regenerative medicine firm faces growth hurdles - Investing.com India
AVITA Medical (FRA:51KA) Revenue per Share : €1.96 (TTM As of Jun. 2024) - GuruFocus.com
AVITA Medical (FRA:51KA) Dividend Payout Ratio : 0.00 (As of Jun. 2024) - GuruFocus.com
AVITA Medical (FRA:51KA) Inventories, Raw Materials & Compo - GuruFocus.com
AVITA Medical, Inc. (NASDAQ:RCEL) Holdings Lowered by Bank of New York Mellon Corp - Defense World
AVITA Medical (FRA:51KA) Total Assets : €81.59 Mil (As of Jun. 2024) - GuruFocus.com
AVITA Medical (FRA:51KB) Free Cash Flow : €-53.82 Mil (TTM As of Jun. 2024) - GuruFocus.com
AVITA Medical (FRA:51KA) Momentum Rank : 4 (As of Sep. 29, 2024) - GuruFocus.com
AVITA Medical Inc (ASX:AVH) Q2 2024 Earnings Call Transcript Hig - GuruFocus.com
Top High Growth Tech Stocks To Watch In September 2024 - Simply Wall St
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference - StockTitan
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avita Medical Inc Stock (RCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| O'Toole David D | CFO |
Feb 28 '24 |
Buy |
17.39 |
1,250 |
21,738 |
18,734 |
| CORBETT JAMES | CEO |
Dec 26 '23 |
Sale |
13.29 |
1,445 |
19,204 |
11,580 |
| COOK JEREMY CURNOCK | Director |
Dec 13 '23 |
Sale |
12.27 |
2,518 |
30,896 |
20,596 |
| O'Toole David D | CFO |
Dec 12 '23 |
Buy |
12.45 |
950 |
11,828 |
17,484 |
| O'Toole David D | CFO |
Dec 01 '23 |
Buy |
10.68 |
500 |
5,340 |
16,534 |
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):